Fujian Aonong Biological Technology Group Incorporation Limited

SHSE:603363 Stock Report

Market Cap: CN¥3.2b

Fujian Aonong Biological Technology Group Incorporation Past Earnings Performance

Past criteria checks 0/6

Fujian Aonong Biological Technology Group Incorporation's earnings have been declining at an average annual rate of -59.4%, while the Food industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 16.9% per year.

Key information

-59.4%

Earnings growth rate

-55.5%

EPS growth rate

Food Industry Growth7.2%
Revenue growth rate16.9%
Return on equityn/a
Net Margin-28.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Shares Not Telling The Full Story

Aug 22
Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Shares Not Telling The Full Story

Market Cool On Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Revenues Pushing Shares 30% Lower

May 02
Market Cool On Fujian Aonong Biological Technology Group Incorporation Limited's (SHSE:603363) Revenues Pushing Shares 30% Lower

Revenue & Expenses Breakdown

How Fujian Aonong Biological Technology Group Incorporation makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603363 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2411,206-3,1801,16976
30 Jun 2414,047-3,3821,16897
31 Mar 2417,048-3,7631,147116
31 Dec 2319,458-3,6511,117149
30 Sep 2321,387-1,7561,076162
30 Jun 2322,862-1,1711,105172
31 Mar 2322,276-8661,100176
31 Dec 2221,613-1,0381,098162
30 Sep 2220,119-1,5901,136148
30 Jun 2218,636-2,0341,028134
31 Mar 2218,299-2,0341,016126
31 Dec 2118,038-1,520990114
30 Sep 2117,504-43292898
30 Jun 2115,6497290788
31 Mar 2113,66358483574
31 Dec 2011,51757374065
30 Sep 208,86049162061
30 Jun 207,16534652958
31 Mar 206,19716348563
31 Dec 195,7882947473
30 Sep 195,7943950586
30 Jun 195,73635526102
31 Mar 195,74633547107
31 Dec 185,76230571110
30 Sep 185,67549609107
30 Jun 185,37661566159
31 Mar 185,13799602132
31 Dec 174,903108631107
30 Sep 174,96011963381
31 Dec 164,978917220
31 Dec 154,013346760
31 Dec 144,184436260

Quality Earnings: 603363 is currently unprofitable.

Growing Profit Margin: 603363 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603363 is unprofitable, and losses have increased over the past 5 years at a rate of 59.4% per year.

Accelerating Growth: Unable to compare 603363's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 603363 is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (-5.8%).


Return on Equity

High ROE: 603363's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 10:54
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fujian Aonong Biological Technology Group Incorporation Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jia ChenChangjiang Securities Co. LTD.
Jiarui LuGuosen Securities Co., Ltd.
Nicolas WangHaitong International Research Limited